Stock listing

Cboe Canada:NVON Novo Nordisk A/S Stock

Canadian listing (Cboe Canada) of Novo Nordisk A/S · home listing Copenhagen:NOVOB

Follow Novo Nordisk A/S into a list and get an email when it puts out news.

Share price · NEO:NVON

$4.20 CAD 0.00 (0.0%)

Close on Oct 27, 2026

Day range
$4.20 – $4.24 CADOct 27, 2026
Volume
16,741 sharesOct 27, 2026
Market cap
$18.54B CADAt the close on Oct 27, 2026 · price × 4.41B shares outstanding
Novo Nordisk A/S logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NYSE:NVO$38.67 USD-0.38 (-1.0%)6,775,105$38.58$39.03$38.54$39.05Close on Oct 27, 2026
Xetra:NOV€34.70 EUR-0.18 (-0.5%)114,332€35.03€35.08€34.54€34.88Close on Oct 27, 2026
TSX:NOVO$16.87 CAD-0.09 (-0.5%)5,589$16.97$17.00$16.87$16.96Close on Oct 27, 2026
OTC:NONOF$38.98 USD+0.084 (+0.2%)155,794$38.92$39.38$38.59$38.90Close on Oct 27, 2026
Cboe Canada:NVON$4.20 CAD0.00 (0.0%)16,741$4.21$4.24$4.20$4.20Close on Oct 27, 2026
Frankfurt:NOV€35.60 EUR+0.70 (+2.0%)13,652€34.76€35.80€34.76€34.90Close on Oct 30, 2026
B3:N1VO3425.75 BRL+1.47 (+6.1%)42,01725.7826.1025.6924.28Close on Oct 27, 2026
Frankfurt:NOVA€35.64 EUR+0.80 (+2.3%)—€34.62€35.64€34.62€34.84Close on Oct 30, 2026
LSE:0TDD$38.66 USD-0.308 (-0.8%)30,366$39.16$39.17$38.55$38.97Close on Oct 27, 2026
Dusseldorf:NOVA€35.72 EUR+1.08 (+3.1%)—€34.88€35.74€34.88€34.64Close on Oct 30, 2026
Hamburg:NOV€35.52 EUR+0.915 (+2.6%)—€34.85€35.52€34.85€34.61Close on Oct 30, 2026
Dusseldorf:NOV€35.62 EUR+0.96 (+2.8%)3€34.83€35.72€34.83€34.66Close on Oct 30, 2026
Munich:NOV€34.97 EUR-0.21 (-0.6%)30€34.90€34.97€34.77€35.18Close on Oct 27, 2026
Munich:NOVA€35.14 EUR0.00 (0.0%)—€35.14€35.14€35.14€35.14Close on Oct 27, 2026
Ticker
Cboe Canada:NVON
Asset type
Stock
Exchange
Cboe Canada
Currency
CAD

What changed lately

Calls

Replays

  • Novo Nordisk (Copenhagen:NOVO B) Q2 2026 Earnings Call

    Wed, Aug 05, 2026 · 7:00 AM ET

    Watch Transcript

  • Novo Nordisk (Copenhagen:NOVO B) Q1 2026 Earnings Call

    Wed, May 06, 2026 · 7:00 AM ET

    Watch Transcript

  • Novo Nordisk (Copenhagen:NOVO B) Q4 2025 Earnings Call

    Wed, Feb 04, 2026 · 7:00 AM ET

    Watch Transcript

Latest news

Novo and Hengrui Pharma enter exclusive license agreement for once-weekly oral GLP-1/GIP dual receptor agonist HRS-1596

Sep 29, 2026

Highlights to be presented at Novo’s Capital Markets Day 2026

Sep 21, 2026

Novo Nordisk enters next chapter to bring better health to more people, supported by ‘Novo’ rebrand and updated corporate culture

Sep 14, 2026

Novo Nordisk A/S: IT Security incident at Novo Nordisk

Jun 11, 2026

Novo Nordisk: Wegovy® pill (semaglutide tablets) becomes first daily GLP-1 weight-loss pill approved in the UK

Jun 11, 2026

Novo Nordisk introduces updated Rybelsus® tablet formulation in Canada for adults living with type 2 diabetes

Jun 9, 2026

Wegovy® pill launches in the UAE as Novo Nordisk expands global access to obesity care

Jun 3, 2026

Novo Nordisk advances cardiometabolic pipeline with new data featuring CagriSema and zenagamtide at the American Diabetes Association's 2026 Scientific Sessions

May 27, 2026

Novo Nordisk Introduces Extra Savings for Canadians Who Choose Ozempic®

May 26, 2026

Novo Nordisk global observational study reveals 2 in 5 people with cardiovascular disease have cardiovascular inflammation, increasing their risk of heart attack and stroke

May 26, 2026

All Novo Nordisk A/S news

Decks

Novo Nordisk A/S on 6ix

News releases
103 in the last 12 months · 116 in all · newest Sep 29, 2026 · oldest 2025
Calls
26 calls with a replay · 26 with a transcript · latest Aug 5, 2026
Decks
230 decks · latest Sep 21, 2026

Where Novo Nordisk A/S is listed

ListingExchangeCountryCurrency
Copenhagen:NOVOB · Home listingCopenhagenDenmarkDKK
NYSE:NVONYSEUnited StatesUSD
Xetra:NOVXetraGermanyEUR
gettex:NOVgettexGermanyEUR
Tradegate:NOVTradegateGermanyEUR
TSX:NOVOTSXCanadaCAD
LS Exchange:A3EU6FLS ExchangeGermanyEUR
Aquis:NOVOBCAquisUnited KingdomDKK
SET:NOVOB80SETThailandTHB
gettex:NOVAgettexGermanyEUR
LSIN:0QIULSINUnited KingdomDKK
OTC:NONOFOTCUnited StatesUSD
BMV:NVONBMVMexicoMXN
Cboe Canada:NVON · This pageCboe CanadaCanadaCAD
Tradegate:NOVATradegateGermanyEUR
Stuttgart:NOVStuttgartGermanyEUR
Frankfurt:NOVFrankfurtGermanyEUR
Lang & Schwarz:A3EU6FLang & SchwarzGermanyEUR
B3:N1VO34B3BrazilBRL
Cboe Canada:NOVOCboe CanadaCanadaCAD
BOATS:NVOBOATSUnited StatesUSD
GPW:NVOGPWPolandPLN
LS Exchange:866931LS ExchangeGermanyEUR
Aquis:NOVOBCAquisUnited KingdomDKK
Turquoise:NOVOBCTurquoiseUnited KingdomDKK
BMV:NOVOBNBMVMexicoMXN
Frankfurt:NOVAFrankfurtGermanyEUR
LSE:0TDDLSEUnited KingdomUSD
BX Swiss:NOVBX SwissSwitzerlandCHF
VIE:NNO2ViennaAustriaEUR
BX Swiss:NVOBX SwissSwitzerlandCHF
Aquis:NOVDAquisUnited KingdomEUR
Lang & Schwarz:866931Lang & SchwarzGermanyEUR
Dusseldorf:NOVADusseldorfGermanyEUR
BIVA:NOVOBNBIVAMexicoMXN
Hamburg:NOVHamburgGermanyEUR
Stuttgart:NOVAStuttgartGermanyEUR
Aquis:NOVDAquisUnited KingdomEUR
Frankfurt:NOV1FrankfurtGermanyEUR
BCBA:NVOBCBAArgentinaARS
Dusseldorf:NOVDusseldorfGermanyEUR
Hanover:NOVHanoverGermanyEUR
Munich:NOVMunichGermanyEUR
Munich:NOVAMunichGermanyEUR
Frankfurt:NOV0FrankfurtGermanyEUR
BSESOF:NOVBSESOFBulgariaEUR
Hamburg:NOVAHamburgGermanyEUR
BCBA:NVOCBCBAArgentinaUSD
BCBA:NVODBCBAArgentinaUSD
BCBA:NVO.CIBCBAArgentinaARS

Log in to ask 6ix AI your own questions about Novo Nordisk A/S.